WORCESTER, Mass., Nov.

An extensive analysis by the Stanford Transportation Group, a leading U.S.-based aviation consultancy, has revealed that the number of best-paying passengers of U.S. airlines has stagnated at low levels while the number of travelers using business aircraft is reaching new highs.

WORCESTER, Mass., March 20, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today clarified the stance of Dr. Gerald Bernstein, the Company's Vice-President for Medical Affairs.

By Tim Simmers It's a guessing game what could happen to nearly 10,000 United Airlines workers in the Bay Area if the giant carrier's rumored merger talks with Continental Airlines come to fruition. But close observers of the U.S.

Generex Biotechnology Corporation (NASDAQ: GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that Dr.